The shortest path to chemistry data for successful drug discovery and development

Validating lead candidates to increase preclinical and clinical trial success requires fast access to relevant chemical reactions and bioactivity data. Success requires tools that help you realize the potential of data-driven drug discovery and development.

See how Reaxys can benefit your organization.

Contact us

Real-time solutions for challenges in pharmaceutical development

Reaxys helps pharmaceutical companies drive successful early drug discovery by helping chemists retrieve relevant literature, precise compound properties and chemical reaction data twice as fast as any other solution.

With powerful search options, expertly curated databases and tools to support in silico profiling, Reaxys helps chemists:

In these interviews, see how expert chemists involved in drug discovery and development leverage Reaxys to improve their workflows.

Pharmaceutical R&D



Building a one-stop platform for chemistry information

When Lundbeck needed a single cheminformatics platform to integrate internal and external data with content from commercial databases, they turned to Reaxys.

Read the solution story

Intro graphic - Customer stories, Reaxys| Elsevier

WuXi AppTec

Solving chemoinformatics challenges with Reaxys

How to best leverage the huge amount of chemical synthesis data available to scientists? Dr. Rujian Ma and Dr. Wenzhong Gao discuss how Reaxys helps over 5,000 chemists at WuXi AppTec deal with chemoinformatics challenges and excel in their work.
Read the solution story

Read more about Ascentage Pharma - Reaxys |Elsevier Solutions

Ascentage Pharma

Finding data for small molecule targeted therapeutics

See how an early drug discovery team at a world-leading pharmaceutical company gets the high-quality, comparable data they need for success.
Read the case study

Solution Story: Merging systems biology & chemistry to streamline the quest for natural, active agents

Oriflame Skin Research Institute

Merging biology & chemistry to streamline search

Oriflame scientists turned to Pathway Studio and Reaxys Medicinal Chemistry to find new targets and active natural ingredients quickly.

Read the solution story

Read more about NCK - Reaxys |Elsevier Solutions


Optimizing reaction conditions and synthesis routes for API production

According to Dr. Anders Lohse, NCK, Reaxys quickly delivers data for optimizing reaction conditions, and synthesis routes for pharmaceutical ingredients.
Read the interview

Read more about Mercachem - Reaxys |Elsevier Solutions


Finding the optimal synthesis route to produce a pharmaceutical substance

Dr. Tommi Meulemans of Mercachem explains how using Reaxys helped find the right method for a compound his team was working on.
See the case study

Read more about Ironwood Pharmaceuticals - Reaxys |Elsevier Solutions

Ironwood Pharmaceuticals

Finding the answers about compound synthesis and availability

According to Dr. Takahashi Nakai of Ironwood Pharmaceuticals, Reaxys provides unique services, including extracted property and reaction data, and links to eMolecules.
See the case study

Read more about Novasep - Reaxys |Elsevier Solutions


Winning a contract for a proof-of-concept study with experimental facts

Dr. Jan Haller of Novasep describes how Reaxys' rapid search workflows helped his team develop a winning synthesis route.
Read the case study

Read more about e-Therapeutics - Reaxys |Elsevier Solutions


Successful data-driven profiling of compound behavior

It's a breakthrough way of developing new drugs, but it requires enormous amounts of clean, accurate data. Find out how Reaxys delivers.
Read about the method

Read more about Hager Bioscienes - Reaxys |Elsevier Solutions

Hager Biosciences

Developing highly sought-after lead compounds for unmet medical needs

Hager Biosciences needed reliable access to accurate medicinal chemistry and synthesis data. Reaxys was perfect for their needs.
See the case study

Read more about Epigen Biosciences - Reaxys |Elsevier Solutions

Epigen Biosciences

Understanding structure–activity relationships and synthesis routes

Epigen Biosciences' cofounder and COO Dr. Fabio Tucci chose Reaxys because it saves time and helps avoid unnecessary optimization steps.
Read the interview

Read more about Seoul National University - Reaxys |Elsevier Solutions

Seoul National University

Finding the synthesis data you need fast

Seoul National University research chemist Hong-Rae Kim explains why he relies on Reaxys and Reaxys Medicinal Chemistry to find the best ways to synthesize nucleosides — and then explore all of their reactions — in less time.
Read the solution story

Ready to take the next step?

Contact us